<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ernawati</style></author><author><style face="normal" font="default" size="100%">Aditiawarman</style></author><author><style face="normal" font="default" size="100%">Salsabila Nabilah Rifdah</style></author><author><style face="normal" font="default" size="100%">Agus Sulistyono</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antihypertensive Choices during Pregnancy in Limited Setting</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antihypertensive agent</style></keyword><keyword><style  face="normal" font="default" size="100%">Chronic hypertension</style></keyword><keyword><style  face="normal" font="default" size="100%">Hypertension during pregnancy</style></keyword><keyword><style  face="normal" font="default" size="100%">Preeclampsia</style></keyword><keyword><style  face="normal" font="default" size="100%">Side effect.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">315-318</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Antihypertensive agents used during pregnancy may vary from institution to institution and depend on resource availability. &lt;strong&gt;Objective:&lt;/strong&gt; This study aimed to determine the profile of antihypertensive drugs used in pregnancy in low-middle-income countries and the impact of these drugs on maternal and fetal outcomes. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; This is a retrospective study on hypertensive pregnant patients admitted to the emergency unit at a tertiary referral Hospital in Indonesia. The type of hypertension during pregnancy, antihypertensive drugs, side effect, and maternal and perinatal outcomes was extracted from medical hospital records. &lt;strong&gt;Results:&lt;/strong&gt; A total of 762 hypertensive pregnant women were recruited; 61 were diagnosed with preeclampsia, 491 were preeclampsia with severe features and 174 were chronic hypertension superimposed preeclampsia, and 81.54% of them received antihypertension therapy. The most commonly prescribed antihypertensive drugs were combination therapy of nifedipine and methyldopa (96.7%), followed by monotherapy of methyldopa (2.3%), nicardipine (1.1%), and nifedipine (0.2%). Most of the patients successfully attained a Systolic blood pressure&amp;lt;160mmHg. Tachycardia was reported in 47 (7.9%) pregnant women who received antihypertensive medication; none reported hypotension and arrhythmia. &lt;strong&gt;Conclusion:&lt;/strong&gt; Nifedipine and methyldopa are choices for an antihypertensive agent in limited resources, either monotherapy or combined. Nifedipine's immediate release can be used with a low risk of hypotension.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article </style></work-type><section><style face="normal" font="default" size="100%">315</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ernawati&lt;sup&gt;1,*&lt;/sup&gt;, Aditiawarman&lt;sup&gt;1&lt;/sup&gt;, Salsabila Nabilah Rifdah&lt;sup&gt;2&lt;/sup&gt;, Agus Sulistyono&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;MD, PHD, MFM Division, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Airlangga – Dr. Soetomo Academic General Hospital, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;MD, Faculty of Medicine, Universitas Airlangga – Dr. Soetomo Academic General Hospital, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>